معرفی
Dr. Cor Lamers is a Researcher at Erasmus MC (Medical Center) in the Medical Oncology department. His work bridges immunology and cancer therapy, focusing on T-cell dynamics, immune checkpoint regulation, and innovative treatment strategies.
- Active in Cancer Immunology
- Specializes in Immune Checkpoint Inhibition
- Applies Kinase Activity Profiling for metastatic cancer
Recent research trends include CD8 T-cell responses in solid tumors, adenovirus-based therapies for glioblastoma, and blood biomarkers for immunotherapy outcomes. His publications highlight collaborations across oncology, hematology, and pharmaceutical sciences.
- 2022: Oncolytic adenovirus trials in recurrent GBM
- 2020: Kinase profiling as immunotherapy predictor
- 2019: CD8 T-cell biomarkers for nivolumab response
While specific awards are not listed here, Lamers' work on cytotoxic T-cell behavior and haploidentical transplantation has informed clinical practices. His supervised work includes unpublished research on immune system dynamics in cancer patients.